Download Taipei Veterans General Hospital reduces blood

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project

Document related concepts

Hemolytic-uremic syndrome wikipedia, lookup

Schmerber v. California wikipedia, lookup

Autotransfusion wikipedia, lookup

Blood donation wikipedia, lookup

Blood transfusion wikipedia, lookup

Hemorheology wikipedia, lookup

Blood type wikipedia, lookup

Men who have sex with men blood donor controversy wikipedia, lookup

Rh blood group system wikipedia, lookup

Plateletpheresis wikipedia, lookup

Jehovah's Witnesses and blood transfusions wikipedia, lookup

Blood bank wikipedia, lookup

Transcript
I am pleased that the Haemonetics TEG system solves one of our
blood management challenges. The TEG system helps us reduce
unnecessary blood transfusions, thus helping us provide better care
to our patients and economic savings to our hospital.“
Dr. Tsou Mei-Yung
Chief
April 2009
Taiwan
Taipei Veterans General Hospital
reduces blood transfusions by 50%
with the TEG® 5000 analyzer
Challenge
Solution
Results
Taipei Veterans General Hospital in
Taiwan depended upon empirically
guided transfusion therapy protocols
both during and after liver transplant
surgery, in part because they lacked
specific point-of-care hemostasis
monitors that would provide
functional information for both
coagulation factors and platelets. This
gap in data led to unnecessary blood
transfusions and blood loss.
Haemonetics introduced the
TEG®5000 Hemostasis Analyzer
System into the hospital’s blood
management program. TEG
monitoring provided surgeons with a
more comprehensive picture of each
patient’s hemostasis, helping them
deliver more targeted treatment,
including the right blood products and
the appropriate medications.
Taipei Veterans General Hospital
reported significant results based
on 40 liver transplant cases:
ƒƒ A 50% reduction in blood
transfusions (e.g., FFP, RBC,
and albumin)
ƒƒ A 55% reduction in blood loss
© 2009,2011 Haemonetics Corporation. Haemonetics and TEG are
trademarks or registered trademarks of Haemonetics Corporation in
the USA other countries, or both.12.2011 USA. COL-CST-000005(AB)
Haemonetics Corporation
400 Wood Road
Braintree, MA 02184
USA
800.225.5297
www.haemonetics.com